Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects

Pharmacology, Toxicology and Pharmaceutical Science

• Autoimmune Disease 100%
• Fragment Antigen-Binding 66%
• Immunogenicity 33%
• Malignant Neoplasm 33%
• Single Chain Fragment Variable Antibody 33%
• Epitope 33%

Biochemistry, Genetics and Molecular Biology

• Fragment Antigen-Binding 100%
• Solution and Solubility 50%
• Immunogenicity 50%
• Single-Chain Variable Fragment 50%

Immunology and Microbiology

• Fragment Antigen-Binding 66%